Diverse Perspectives Help Solve Problems
Diversity is just as crucial to building a successful business as it is to building a vibrant culture. We realize that means not just attracting the best and brightest talent, but also ensuring that our colleagues can thrive in an environment where we champion diversity, equity and inclusion every single day, all around the world.
We want all patients to have equal access to healthcare and accessible, affordable drugs. Within our business, we believe everyone deserves to be seen, heard, and respected for who they are.
That’s why we focus on and invest in making our company an amazing workplace for all. Our Diversity, Equity & Inclusion department leads, around the world, partner with business leaders to make sure our approach and processes reflect our key values.
We want all our colleagues to develop, grow, and succeed. We commit to making that happen, and to sharing and celebrating our successes as we bring together people from all backgrounds, geographies, and perspectives.
Our opportunity parity strategy represents our commitment to increase diversity.
In 2019, we announced representation goals by 2025 of 47 percent for women (globally) and 32 percent for minorities (U.S.) in Vice President (VP) roles and above.
Results so far:
- Representation of women at the VP level and above in 2020 was 38 percent globally (up 5 percent from 2019).
- Representation of minorities in the U.S. at the VP level and above in 2020 was 22 percent (up 2 percent from 2019).
We have publicly disclosed our EEO-1 Reports for 2016 through 2021 in the interest of serving greater transparency and will continue to disclose future EEO-1 Reports as they are filed with the Equal Employment Opportunity Commission (EEOC).
The broad job categories by which the data is portrayed are dictated by EEOC requirements and do not necessarily match the job categories by which Pfizer evaluates its diversity, equity and inclusion (DEI) data. For this reason, meaningful comparisons between EEO-1 Report data and other descriptions of Pfizer’s DEI statistics and disclosures may not be possible. Additionally, the data captured for the report is a snapshot in time; it does not offer full insight into activities such as acquisitions, divestitures, reorganizations, etc., which may significantly alter the colleague demographics and is not indicative of Pfizer’s diversity efforts. We are fully committed to our DEI efforts and our ongoing initiatives to remain a great place to work for all.
For a further discussion of our Human Capital initiative, including our DEI efforts, please refer to the “Human Capital” section of the ESG report.
All areas of our business groups are dedicated to advancing diversity, equity, and inclusion.
In our Global Supply organization, we have adapted enterprise-wide initiatives to drive inclusiveness across our 40+ sites around the world.
Pfizer believes in treating all colleagues fairly, a core aspect of our company value of equity. To that end, we are committed to pay equity as a means to ensure that all colleagues are paid fairly and equitably regardless of gender or race. Pfizer works toward pay equity by evaluating pay practices through annual pay equity studies, market benchmarking, and other steps to assess fair and equitable pay, and by complying with all applicable laws and other obligations regarding pay.
An independent compensation expert reviews Pfizer’s equitable pay practices. Here are the results:
At Pfizer, we believe every person deserves to be seen, heard, and cared for.
This is why Diversity, Equity, and Inclusion is embedded into our Environment, Social, and Governance strategy. We’re focused on building a more inclusive colleague experience, advancing equitable health outcomes, and transforming society through external partnerships. This is a path we choose both mindfully and actively, and it is cultivated by listening, learning, and connecting with our colleagues, patients, and communities.
Learn more about our key performance indicators (KPIs) and progress to date:
Our site-based Colleague Resource Groups (CRGs) help drive inclusion and professional development at Pfizer. CRGs are groups of colleagues who are part of, and/or believe in, the goals of a diverse population., and CRGs are open to anyone who wants to join.
These groups provide a forum through which we can collectively deliver on our Bold Move to make Pfizer an amazing place to work for all.
Through participation in CRGs, colleagues collaborate to foster awareness, respect, and inclusion within the workplace. They CRGs offer support, developmental opportunities, mentoring, and networking opportunities to help their members enhance their skills and advance their careers.
Pfizer’s CRGs are generally aligned to the following affinities:
- Asian: Global Asian Alliance (GAA)
- Black: Global Black Community (GBC)
- Individuals with Disabilities: Disability
- Latino/Hispanic: Pfizer Latino Community
- LGBTQ+ Allies: Out Pfizer Employee Network (OPEN)
- Middle Eastern & North African: Middle Eastern & North African Resource Alliance (MENARA)
- Veterans: Veterans in Pfizer (VIP)
- Women: Pfizer Women’s Resource Group (PWR)
To help us build on the solid foundation of our Colleague Resource Groups, we have also developed strong partnerships with a number of external organizations including:
Our core values are simple, powerful, and interconnected: courage, excellence, equity, and joy.
We recognize that courage, excellence, and joy are only possible when we ensure that all our colleagues feel welcome and included at every step of their Pfizer journey.
If you’re a veteran or a person with a disability who would like to join our global talent community, we encourage you to explore our Pfizer Careers page and apply so you can be part of our purpose—Breakthroughs that Change Patients’ Lives.
Incredible things can happen when people come together with one shared goal. The future of medicine is happening here, and we’re eager to work alongside inspired and inspirational people who want to improve health around the world.
Changing the World Through Equity
Equity is embedded in our corporate values and is core to who we are at Pfizer. We take seriously our role as a world citizen by building and nurturing programs and partnerships that focus on diversity, equity, and inclusion beyond our own company.
Our unique resources allow us to do more for people. Using our global presence and scale, we’re able to make a difference in local communities and the world around us.
- Corporate Compliance
Our Compliance Program represents a shared undertaking from the highest levels of management to the most junior employees.
- EHS Governance
We integrate environment, health, and safety (EHS) into how we run our business to ensure that management of risk and regulatory compliance are overseen at the highest levels of the company. With our EHS Policy as the foundation, implementation of Pfizer's EHS Standards and Audit programs establish the performance expectations for colleagues around the world. Each Pfizer colleague plays a crucial role in facilitating a culture of EHS excellence where all improvements, ideas, and opportunities are welcomed. Our governance framework and culture provide the basis for proactive engagement and shared accountability of EHS across our operations.
- EHS Supply Chain
A network of external suppliers is essential to enable manufacture of medicines and vaccines that deliver breakthroughs that change patients’ lives. Pfizer’s supply chain supports the research, development and manufacturing process by providing flexibility and access to technologies necessary to meet our commitment to patients We are committed to using suppliers that demonstrate strong performance in Environment, Health, and Safety (EHS) management.
- Environmental Sustainability
We recognize that environmental issues can result in profound societal and public health impacts.. Our company purpose—Breakthroughs that change patients’ lives—guides our environmental sustainability priorities, with a focus on climate impact mitigation, conservation of resources, and the reduction of waste arising from our operations.
- Facility Investments
We continue to invest in the groundbreaking science and technology needed to discover tomorrow’s life-saving treatments for patients who need them the most. Our research, development, and manufacturing facilities across the country are fostering next-generation healthcare innovation while creating 30,000 U.S.-based jobs.
- Global Impact
All patients should have access to the medicines they need. Through our partnerships with global health institutions and implementation of novel pricing structures–including donations where appropriate–we blend philanthropy and business approaches to increase access to our medicines and vaccines where they’re needed most.
- Health Safety
We deliver scientific breakthroughs through the relentless collaboration of our talented workforce. Therefore, ensuring the health, safety and well-being of our workforce is critical to delivering our purpose. We continue to advance a comprehensive occupational injury and illness prevention program that enables engagement and productivity.
- Human Rights
We’re committed to conducting business in an ethical and responsible manner. This includes respecting internationally recognized human rights throughout our operations.
- Intellectual Property
The Intellectual Property Principles for Advancing Cures and Therapies (IP PACT) is a groundbreaking, unified declaration of 10 key Intellectual Property (IP) principles. Driven by members of the innovative biopharmaceutical industry, it affirms our strong commitment to innovation and to keeping the needs of patients at the heart of our IP practice
To Our Investors
Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.To Our Investors
Events and Presentations